Bluebird Bio reported $122.29M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amgen AMGN:US $ 3.74B 804M
Applied Genetic Technologies AGTC:US $ 13.58M 4.86M
Arrowhead Research ARWR:US $ 110.25M 19.49M
Avrobio Inc AVRO:US 29.42M 1.46M
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Gilead Sciences GILD:US $ 6393M 89M
Immunogen IMGN:US $ 60.93M 1.62M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
IONIS PHARMACEUT IONS:US $ 199.42M 19.98M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Moderna Inc MRNA:US 1.84B 38M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
YTE INCY:US $ 616.69M 135.42M